StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
3139.T$3110.00-0.16%
Fair $3110.00+0.0%

3139.T

Lacto Japan Co., Ltd.

Consumer Defensive / Packaged FoodsTokyo

$3110.00

-5.00 (-0.16%)

Fairly Valued+0.0%Fair Value $3110.00Fund rank 23/100 · Data gapFallback financials|
SA 34/D
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 16%

FCF escenarios

weak_data · normalized FCF $-185.0M · quality 33.7/100

Data gap 23/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 12/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

34/100

D

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 3139.TLocal privado en este navegador · Lacto Japan Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$31.1B

P/E

7.2x

↓

EV/EBITDA

8.5x

↓

ROE

13.3%

↑

Gross Margin

6.7%

↓

Debt/Equity

1.13

↑
52-Week Range$3110
$3085$4360

TradingView lightweight chart

3139.T price, volumen y niveles de valoración

Último $3,110Periodo +323.1%
Fair value: $3,110

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+7.4%

FCF CAGR

—

FCF margin

-1.0%

FCF / Net income

-0.42x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $182.82B · net income $4.32B · FCF $-1.79B

2022-FY → 2025-FY

Gross margin

6.7%+1.7% pts

Operating margin

3.3%+1.2% pts

Net margin

2.4%+0.8% pts

FCF margin

-1.0%+6.2% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$182.82B$182.82B$170.91B$158.33B$147.42B
Net Income$4.32B$4.32B$3.15B$2.05B$2.29B
EBITDA$6.79B$6.79B$5.05B$3.44B$3.64B
EPS——314.59204.44228.80
Gross Margin6.7%6.7%5.9%5.0%5.1%
Operating Margin3.3%3.3%2.6%2.0%2.0%
Net Margin2.4%2.4%1.8%1.3%1.6%
Balance Sheet
Debt/Equity1.131.131.191.251.37
Current Ratio1.561.56———
Cash Flow
Free Cash Flow$-1.79B$-1.79B$-185.0M$2.06B$-10.57B
Returns
ROE13.3%13.3%11.4%8.3%10.2%
Valuation
P/E7.207.209.149.289.00
EV/EBITDA8.478.4710.4112.2312.38
P/B0.960.961.040.770.92
Growth & Yield
Revenue Growth7.0%7.0%7.9%7.4%—
EPS Growth——53.9%-10.6%—
Dividend Yield4.2%4.2%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -5.1%

Total return

-5.1%

Start / end P/E

n/dx → n/dx

EPS bridge

314.59 → n/d

Residual

-9.3%

EPS growthn/d
Multiple reratingn/d
Dividend+4.2%
Residual / FX / buybacks / cross-term-9.3%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.